News | Artificial Intelligence | September 04, 2019

Global Diagnostics Australia Incorporates AI Into Radiology Applications

Partnering with Aidoc to identify and prioritize patients with time-sensitive medical conditions

Global Diagnostics Australia Incorporates AI Into Radiology Applications

September 4, 2019 — Global Diagnostics Australia (GDA), a subsidiary of the Integral Diagnostics Group (IDX), has adopted artificial intelligence (AI) applications into its radiology workflow, and is one of the first diagnostic imaging companies in Australia to do so. GDA has partnered with AI company Aidoc to incorporate their algorithms into GDA's care management pathway. These AI applications will expedite patient diagnosis and treatment for several head, neck and chest conditions.

Aidoc's "Always-on" AI solution analyzes medical images and prioritizes the patient list  to ensure that the most critical are diagnosed and treated first. The introduction of AI by GDA marks a milestone for Aidoc as it expands into Australia.

Aidoc has recently received Therapeutic Goods of Australia (TGA) clearance, and already has U.S. Food and Drug Administration (FDA) approvals and European Union CE markings on AI applications for three medical conditions: intracranial hemorrhage, pulmonary embolism and cervical-spine fracture.

As well as onsite hospital radiology services, GDA also provides teleradiology services to remote and rural parts of Western Australia. Using AI to flag critical findings for these patients helps expediate their care when time is critical, or when they need to be transferred to larger facilities in the metropolitan area for urgent treatment.

"The increase in demand for radiology services in regional areas has created an increased workload for radiologists servicing the regions. AI is being used to effectively triage the truly urgent cases, and this allows the radiologist to appropriately prioritize patients in most need of care. The application provides additional peace of mind for radiologists, patients and for referring doctors, that urgent life-threatening conditions are found and treated faster. AI has arrived and it is here to stay, it is going to materially improve patient care and service well into the future," stated Nazar Bokani, M.D., clinical director, GDA.

For more information: www.aidoc.com

Related Content

Densitas Wins Major Procurement of Breast Density Software for DIMASOS Breast Screening Trial
News | Breast Density | September 20, 2019
Densitas Inc. announced it has won a procurement of its densitas densityai software for deployment in up to 24 breast...
Screening Mammography Could Benefit Men at High Risk of Breast Cancer
News | Mammography | September 18, 2019
Selective mammography screening can provide potentially lifesaving early detection of breast cancer in men who are at...
The Artis icono biplane angiography system is designed for use in neurointerventions and interventional radiology

The Artis icono biplane angiography system is designed for use in neurointerventions and interventional radiology. Image courtesy of Siemens Healthineers.

Technology | Angiography | September 17, 2019
The U.S. Food and Drug Administration (FDA) has cleared the Artis icono, a high-precision family of angiography systems...
Varian Unveils Ethos Solution for Adaptive Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian...
3D Systems Earns Additional FDA Clearance for D2P Medical 3-D Printing Software

3D Systems’ D2P FDA-cleared software allows clinicians to 3-D-print diagnostic patient-specific anatomic models. Image courtesy of 3D Systems.

Technology | Medical 3-D Printing | September 12, 2019
3D Systems has received additional U.S. Food and Drug Administration (FDA) 510(k) clearance for its D2P software...
FDA Clears GE Healthcare's Critical Care Suite Chest X-ray AI
Technology | X-Ray | September 12, 2019
GE Healthcare announced the U.S. Food and Drug Administration’s (FDA) 510(k) clearance of Critical Care Suite, a...
Richardson Healthcare Receives CE Mark Approval for ALTA750 Canon/Toshiba CT Replacement Tube
News | Computed Tomography (CT) | September 11, 2019
Richardson Healthcare, a Division of Richardson Electronics Ltd., announced it has received CE Mark approval for the...
Bayer Introduces Medrad Stellant Flex CT Injection System
Technology | Contrast Media Injectors | September 11, 2019
Bayer announced the introduction of the Medrad Stellant Flex computed tomography (CT) injection system. Stellant Flex...
iCAD's ProFound AI Wins Best New Radiology Solution in 2019 MedTech Breakthrough Awards
News | Computer-Aided Detection Software | September 09, 2019
iCAD Inc. announced MedTech Breakthrough, an independent organization that recognizes the top companies and solutions...
Imaging Biometrics and Medical College of Wisconsin Awarded NIH Grant
News | Neuro Imaging | September 09, 2019
Imaging Biometrics LLC (IB), in collaboration with the Medical College of Wisconsin (MCW), has received a $2.75 million...